| Chelsea Elizabeth Dresner, CRNA | |
|
727 Hospital Dr, Shelbyville, KY 40065-1660 | |
| (502) 647-4085 | |
| (502) 647-4098 |
| Full Name | Chelsea Elizabeth Dresner |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 727 Hospital Dr, Shelbyville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285209585 | NPI | - | NPPES |
| 300072027 | Medicaid | IN | |
| 7100739470 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3016131 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Jewish Hospital - Shelbyville | Shelbyville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
| Anesthesiology Consultants Enterprises, Pllc | 9830268671 | 36 |
News Archive
The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.
One in 10 Canadians have problems affording medications they have been prescribed, and one in four people without drug insurance cannot afford to have their prescriptions filled, according to a study in CMAJ.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-induced rhinoconjunctivitis.
Led by researchers at Loughborough University as part of the Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, the pilot study into bus drivers' sedentary behaviour (prolonged sitting) during and outside working hours is the first of its kind to directly measure periods of inactivity in a sample of drivers using an activPAL3™ accelerometer.
Almac has established a dedicated mass spectrometry laboratory in their European Headquarters, Craigavon, UK.
› Verified 3 days ago
| Entity Name | Anesthesiology Consultants Enterprises, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427246198 PECOS PAC ID: 9830268671 Enrollment ID: O20080520000047 |
News Archive
The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.
One in 10 Canadians have problems affording medications they have been prescribed, and one in four people without drug insurance cannot afford to have their prescriptions filled, according to a study in CMAJ.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-induced rhinoconjunctivitis.
Led by researchers at Loughborough University as part of the Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, the pilot study into bus drivers' sedentary behaviour (prolonged sitting) during and outside working hours is the first of its kind to directly measure periods of inactivity in a sample of drivers using an activPAL3™ accelerometer.
Almac has established a dedicated mass spectrometry laboratory in their European Headquarters, Craigavon, UK.
› Verified 3 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.
One in 10 Canadians have problems affording medications they have been prescribed, and one in four people without drug insurance cannot afford to have their prescriptions filled, according to a study in CMAJ.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-induced rhinoconjunctivitis.
Led by researchers at Loughborough University as part of the Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, the pilot study into bus drivers' sedentary behaviour (prolonged sitting) during and outside working hours is the first of its kind to directly measure periods of inactivity in a sample of drivers using an activPAL3™ accelerometer.
Almac has established a dedicated mass spectrometry laboratory in their European Headquarters, Craigavon, UK.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea Elizabeth Dresner, CRNA Po Box 909, Louisville, KY 40201-0909 Ph: (502) 588-0328 | Chelsea Elizabeth Dresner, CRNA 727 Hospital Dr, Shelbyville, KY 40065-1660 Ph: (502) 647-4085 |
News Archive
The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.
One in 10 Canadians have problems affording medications they have been prescribed, and one in four people without drug insurance cannot afford to have their prescriptions filled, according to a study in CMAJ.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-induced rhinoconjunctivitis.
Led by researchers at Loughborough University as part of the Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, the pilot study into bus drivers' sedentary behaviour (prolonged sitting) during and outside working hours is the first of its kind to directly measure periods of inactivity in a sample of drivers using an activPAL3™ accelerometer.
Almac has established a dedicated mass spectrometry laboratory in their European Headquarters, Craigavon, UK.
› Verified 3 days ago
William D Smith Jr., CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Jerred Davis Mccarty, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Donald David Hart Ii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Alexis Jayne Chambers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Rosalie Spreen Gray, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Sarah Michelle Sanders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |